Precision Health

A Stanford clinical trial that provided proactive, personalized care to participants detected overlooked health conditions and risks.

Years-long tracking of individuals’ biology helped define what it meant for them to be healthy and showed how changes from the norm could signal disease, a Stanford-led study reports.

Stanford scientists and their collaborators have devised an algorithm to predict the risk of a disease that, untreated, can lead to heart attack or stroke.

Clinicians may be able to determine whether people with post-traumatic stress disorder will respond to psychotherapy by analyzing a key brain network and memory, according to Stanford researchers.

Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.

Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.

Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.

Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.

An antibody to a protein on blood-forming stem cells may allow bone marrow transplants without the need for chemotherapy and radiation, according to a Stanford study.

A nurse-scientist at Lucile Packard Children’s Hospital Stanford has discovered a passion for science, and advocates for bringing the nursing perspective into clinical research.

Stanford researchers have identified 20 genes that can predict an individual’s likelihood of developing a severe form of dengue fever with about 80 percent accuracy.